Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06568432

Effect of CRP and SAA Point-of-care Testing on Antibiotic Prescribing for Acute Respiratory-tract Infections

Effect of C-reactive Protein and Serum Amyloid a Point-of-care Testing on Antibiotic Prescribing for Acute Respiratory-tract Infections At Village Clinics in China: a Study Protocol for a Cluster Randomised Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
19,424 (estimated)
Sponsor
Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The study was a practical, cluster-randomized controlled trial to evaluate the impact of CRP and SAA point-of-care testing (CRP\&SAA POCT) on antibiotic prescribing in patients with acute respiratory-tract infections (ARI) at primary care facilities in rural China.

Detailed description

The study was a practical, cluster-randomized controlled trial to evaluate the impact of CRP and SAA point-of-care testing (CRP\&SAA POCT) on antibiotic prescribing in patients with acute respiratory-tract infections (ARI) at primary care facilities in rural China. The study includes two arms, in which CRP\&SAA POCT will be provided in 20 village clinics in the intervention arm. Additional physician training on the use of CRP\&SAA POCT (including centralized training, distribution of physician training manuals, and desk reminders) and patient education sheets (to help patients understand the help of CRP\&SAA POCT in guiding their care) will also be provided;The control arm will not receive any intervention and will serve as the control (usual care). The primary outcome is the proportion of patients who are diagnosed with ARIs and prescribed antibiotics during their initial visit (defined as no prescription record at the current institution within the preceding 14 days) in both study arms.

Conditions

Interventions

TypeNameDescription
DEVICECRP+SAA POCTCRP+SAA POCT will be provided in 20 village clinics in the intervention group

Timeline

Start date
2025-02-15
Primary completion
2025-08-15
Completion
2025-08-15
First posted
2024-08-23
Last updated
2025-03-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06568432. Inclusion in this directory is not an endorsement.